91 related articles for article (PubMed ID: 4370644)
1. Monoaminergic enzymes other than MAO.
Goldstein M
Adv Biochem Psychopharmacol; 1974; 12(0):93-4. PubMed ID: 4370644
[No Abstract] [Full Text] [Related]
2. Molecular geometry and adrenergic drug activity.
Patil PN; Miller DD; Trendelenburg U
Pharmacol Rev; 1974 Dec; 26(4):323-92. PubMed ID: 4156804
[No Abstract] [Full Text] [Related]
3. [Relation among plasma dopamine beta-hydroxylase, monoamine oxidase and Cu++].
Stagni S; Mello P; Gualandi S; Guidi M; Illuminati B; Scanabissi E
Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1603-6. PubMed ID: 7459081
[TBL] [Abstract][Full Text] [Related]
4. MAO, DBH and COMT: the effect of anxiety.
Mathew RJ; Ho BT; Kralik P; Taylor D; Claghorn JL
J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):25-8. PubMed ID: 7440522
[TBL] [Abstract][Full Text] [Related]
5. [Effect of amitriptyline on the activity of enzymes participating in biogenic amine metabolism in patients with affective disorders].
Matsumoto H; Pietruszewska I; Marcjan K
Psychiatr Pol; 1983; 17(5-6):417-20. PubMed ID: 6669662
[No Abstract] [Full Text] [Related]
6. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
[TBL] [Abstract][Full Text] [Related]
7. [Metabolism and pathology of catecholamines].
Traba ML
Rev Clin Esp; 1981 Jul 15-31; 162(1-2):5-13. PubMed ID: 6117933
[No Abstract] [Full Text] [Related]
8. [Effect of hospitalization on the activity of enzymes of biogenic amine metabolism and on the mood of healthy volunteers].
Matsumoto H; Pietruszewska I; Stencka K; Pacyna M; Lewicka-Wysocka H; Roguska E
Pol Tyg Lek; 1982 Jul; 37(23):675-7. PubMed ID: 7177961
[No Abstract] [Full Text] [Related]
9. Cholinergic mechanism--monoamines relation in certain brain structures.
Izquierdo JA
Prog Drug Res; 1972; 16():334-63. PubMed ID: 4405290
[No Abstract] [Full Text] [Related]
10. Genetic studies of CSF monoamine metabolites.
Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
[No Abstract] [Full Text] [Related]
11. [Relationship between catecholamines, dopamine beta hydroxylase and cyclic AMP in acute myocardial infarct].
Prikryl P; Rysánek K; Továrek J; Bílková B; Kunovská M
Cas Lek Cesk; 1979 Aug; 118(32-33):1010-5. PubMed ID: 228852
[No Abstract] [Full Text] [Related]
12. [Comparative study of catalytic properties of mink and rat liver monoamine oxidase].
Iagodina OV
Zh Evol Biokhim Fiziol; 2008; 44(6):570-6. PubMed ID: 19198157
[TBL] [Abstract][Full Text] [Related]
13. Stereospecific transport carrier systems for L-tyrosine and L-tryptophan in relation to monoamine synthesis.
Bruinvels J; Moleman P
Essays Neurochem Neuropharmacol; 1981; 5():1-24. PubMed ID: 7014213
[No Abstract] [Full Text] [Related]
14. [Monoamine and monoamine enzyme abnormalities in childhood autism].
Garnier C; Barthelemy C; Garreau B; Jouve J; Muh JP; Lelord G
Encephale; 1983; 9(3):201-62. PubMed ID: 6317336
[TBL] [Abstract][Full Text] [Related]
15. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
Anokhina IP; Gamaleia NB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
[No Abstract] [Full Text] [Related]
16. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors.
Baldessarini RJ
Psychopharmacol Bull; 1984; 20(2):224-39. PubMed ID: 6728992
[No Abstract] [Full Text] [Related]
17. [Monoaminergic activity acts on the visual evoked potentials].
Magos T
Neuropsychopharmacol Hung; 2004 Oct; 6(3):144-52. PubMed ID: 15816305
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical studies in a mouse teratoma with neuroepithelial differentiation. Presence of cyclic AMP, serotonin and enzymes of the serotonergic, adrenergic and cholinergic systems.
Orenberg EK; Vandenberg SR; Barchas JD; Herman MM
Brain Res; 1976 Jan; 101(2):273-81. PubMed ID: 1140
[TBL] [Abstract][Full Text] [Related]
19. [Modifications of cerebral amine metabolism in psychiatric illness].
Linkowski P; Mendlewicz J
Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
[TBL] [Abstract][Full Text] [Related]
20. Studies on psychotropic drugs. XVII. Effects of 3-chloro-5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-5(H)-dibenz-(b,f)-azepine dihydrochloride monohydrate (Y-4153) on the metabolism of biogenic amines.
Nakanishi M; Setoguchi M
Arzneimittelforschung; 1973 Jun; 23(6):806-10. PubMed ID: 4740766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
